LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring

NCT00256386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2006-11-30

No results posted yet for this study

Summary

Errors and preventable adverse events associated with medication prescription and dispensing are common, and the difference between guideline recommendations and the actual frequency of laboratory monitoring is substantial. This study evaluates three interventions to improve laboratory monitoring at initiation of medication therapy: an electronic medical record reminder to the prescribing clinician (EMR), an automated voice message to the patient (AVM), and a pharmacy team outreach (Pharmacy) compared to usual care (UC).

Conditions

  • Safety

Interventions

DEVICE

Electronic Medical Record (EMR) to clinician's in-basket

DEVICE

Automated Voice Message (AVM) reminder to patient's phone

PROCEDURE

Pharmacy Team phone call-letter followup

Sponsors & Collaborators

  • Garfield Memorial Fund

    collaborator OTHER
  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Adrianne C. Feldstein, MD, MS · Northwest Permanente

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00256386 on ClinicalTrials.gov